Major Study into the Effectiveness of the Corona Vaccine in HIV Patients
A large study is being set up in Africa to find out how effective the Moderna corona vaccine is among people who are HIV positive.
About 14,000 subjects in eight countries are taking part in the study, report research organizations CoVPN and the South African Medical Research Council.
It would be the first significant study specifically designed to look at how people with HIV, the virus that can cause AIDS, respond to the vaccine. Therefore, it is also examined what the optimal dose is for that group, for example.
According to the organizations, researchers can also immediately evaluate how useful the vaccine is against the new Omikron variant of the coronavirus.
The study will be called Ubuntu and will be set up in Zimbabwe, Eswatini (former Swaziland), Botswana, Malawi, Zambia, Uganda, Kenya and South Africa. An estimated 13 percent of the population is infected with HIV in the latter country.